@prefix bibo: <http://purl.org/ontology/bibo/> .
@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-UoB-XB000701 a mbo:MassSpectrum ;
    dcterms:creator "Tara J. Bowen, University of Birmingham" ;
    dcterms:date "2023-04-25"^^xsd:date ;
    dcterms:identifier "MSBNK-UoB-XB000701" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:references [ a bibo:Article ;
            rdfs:label "Bowen, T.J.; Southam, A.D.; Hall, A.R.; Weber, R.J.M.; Lloyd, G.R.; Macdonald, R.; Wilson, A.; Pointon, A.; Viant, M.R. Simultaneously discovering the fate and biochemical effects of xenobiotics through untargeted metabolomics. Nat. Commun. (under review)" ] ;
    dcterms:rights " under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Dionex Ultimate 3000 UHPLC Thermo Scientific; Q Exactive Focus Orbitrap MS Thermo Scientific" ;
            mbo:collision_energy "25,60,100% (stepped)" ;
            mbo:column_name "Accucore 150 Amide, 2.6um, 2.1x100mm, Thermo Scientific" ;
            mbo:flow_gradient "99/1 at 0 min, 99/1 at 1 min, 85:15 at 3 min, 50/50 at 6 min, 5/95 at 9 min, 5/95 at 10 min, 99/1 at 10.5 min, 99/1 at 15 min" ;
            mbo:flow_rate "0.5 mL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-FT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "17500" ;
            mbo:retention_time "0.007 min" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "5-(4-fluorophenyl)-1-[2-(4-hydroxy-6-oxooxan-2-yl)ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide",
                "Atorvastatin IMpurity H",
                "atorvastatin_BTP_M1" ;
            mbo:ch_compound_class "N/A; Biotransformation product" ;
            mbo:ch_exact_mass 5.402424e+02 ;
            rdfs:seeAlso cas:125995-03-1,
                chemspider:11311568,
                pubchem:CID13923664 ;
            schema:inChI "InChI=1S/C33H33FN2O4/c1-21(2)31-30(33(39)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-27-19-26(37)20-28(38)40-27/h3-16,21,26-27,37H,17-20H2,1-2H3,(H,35,39)" ;
            schema:inChIKey inchikey:OUCSEDFVYPBLLF-UHFFFAOYSA-N ;
            schema:molecularFormula "C33H33FN2O4" ;
            schema:name "5-(4-fluorophenyl)-1-[2-(4-hydroxy-6-oxooxan-2-yl)ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide",
                "Atorvastatin IMpurity H",
                "atorvastatin_BTP_M1" ;
            schema:smiles "CC(C)C1=C(C(=C(N1CCC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=CC=C4)C(=O)NC5=CC=CC=C5" ] ;
    mbo:has_peak [ mbo:intensity 2.39978e+04 ;
            mbo:mz 9.50492e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 79 ],
        [ mbo:intensity 4.36141e+04 ;
            mbo:mz 3.391584e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 144 ],
        [ mbo:intensity 3.019816e+05 ;
            mbo:mz 3.80202e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 8.5804e+04 ;
            mbo:mz 3.812053e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 284 ],
        [ mbo:intensity 5.89462e+04 ;
            mbo:mz 4.061813e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 195 ],
        [ mbo:intensity 7.83437e+04 ;
            mbo:mz 4.992388e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 259 ],
        [ mbo:intensity 4.08706e+04 ;
            mbo:mz 1.150543e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 135 ],
        [ mbo:intensity 3.62052e+04 ;
            mbo:mz 1.330449e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 120 ],
        [ mbo:intensity 2.46829e+04 ;
            mbo:mz 2.070606e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 82 ],
        [ mbo:intensity 2.95961e+04 ;
            mbo:mz 2.200682e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 98 ],
        [ mbo:intensity 2.76624e+04 ;
            mbo:mz 2.350788e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 92 ],
        [ mbo:intensity 3.49039e+04 ;
            mbo:mz 2.381026e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 115 ],
        [ mbo:intensity 6.50056e+04 ;
            mbo:mz 3.201444e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 215 ],
        [ mbo:intensity 2.006183e+05 ;
            mbo:mz 3.38155e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 664 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 5.412498e+02 ;
            mbo:precursor_mz 5.412497e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 14 ;
    mbo:pk_splash "splash10-001r-0019100000-f97fdf7a3c88cb524eca" ;
    rdfs:comment "INTERNAL_ID 13341" ;
    skos:definition "atorvastatin_BTP_M1; LC-ESI-FT; MS2; CE: 25,60,100%; R=17500; [M+H]+" .

